The FISH (Fluorescence In Situ Hybridization) Microdeletion Detection for Williams Syndrome test is a specialized genetic diagnostic procedure available at DNA Labs UAE. Priced at 1510 AED, this test is designed to identify the specific microdeletion in the 7q11.23 region of chromosome 7, which is characteristic of Williams Syndrome. Williams Syndrome is a genetic disorder that affects many parts of the body and is known for causing developmental delays, cardiovascular issues, and unique facial features among affected individuals. The FISH test uses fluorescent probes to visualize the presence or absence of genetic material in this specific chromosome region, providing a reliable diagnosis of Williams Syndrome. This test is crucial for early detection and management of the syndrome, offering families and healthcare providers vital information for care planning.
The Fish - Prader Willi Syndrome SNRPN Test is a specialized genetic examination aimed at diagnosing Prader-Willi Syndrome (PWS), a complex genetic disorder characterized by a variety of physical, mental, and behavioral features. This test specifically targets the SNRPN gene, which plays a crucial role in the development of PWS. It employs fluorescence in situ hybridization (FISH) technology to detect abnormalities associated with the SNRPN gene, such as deletions or uniparental disomy, which are common genetic mechanisms underlying Prader-Willi Syndrome.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test provides a reliable diagnosis for families seeking answers to developmental delays, feeding difficulties in infancy, followed by excessive eating and weight gain in older children and adults, among other symptoms associated with PWS. The cost of the test is 1500 AED, making it a valuable investment for those in need of a definitive diagnosis, which can lead to early intervention and management strategies tailored to the specific needs of individuals with Prader-Willi Syndrome.
The CYP3A4*22 Genotyping Test is a specialized diagnostic tool designed to analyze the CYP3A4 gene, specifically the *22 allele, to predict an individual's response to various medications. This test is crucial because the CYP3A4 enzyme is responsible for metabolizing approximately half of all drugs in the market, including statins, antipsychotics, and several cancer medications. Variations in the CYP3A4 gene, such as the *22 allele, can significantly affect drug metabolism, leading to either suboptimal drug efficacy or increased risk of adverse drug reactions.
Performed at DNA Labs UAE, the test aims to provide personalized medication guidance based on genetic makeup. By identifying whether an individual has the CYP3A4*22 variant, healthcare providers can adjust drug dosages or choose alternative medications, enhancing treatment effectiveness and safety.
The cost of the CYP3A4*22 Genotyping Test at DNA Labs UAE is 1500 AED. This investment in personalized medicine not only contributes to more tailored healthcare strategies but also minimizes the trial-and-error approach often associated with prescribing medications, offering a more efficient and patient-centered approach to medical treatment.
The Complement Total CH50 Test is a diagnostic procedure designed to evaluate the overall functionality and activity of the complement system, which plays a crucial role in the body's immune response. By measuring the ability of the complement system to lyse sheep red blood cells coated with antibodies, this test can help in the diagnosis of various immune disorders, including autoimmune diseases and recurrent bacterial infections. It assesses the integrity of the classical pathway of the complement system, providing insights into potential deficiencies or abnormalities.
The test is offered by DNA Labs UAE, a reputable facility known for its advanced diagnostic services. The cost for undergoing the Complement Total CH50 Test at DNA Labs UAE is 1490 AED. This investment can be invaluable for individuals experiencing symptoms suggestive of complement system issues or for those who require monitoring of known complement-related conditions. DNA Labs UAE ensures accurate and reliable results, utilizing state-of-the-art technology and methodologies to support patient diagnosis and management.
The Myelin Associated Glycoprotein-Sulfated Glucuronic Paragloboside (MAG-SGPG) IgM Test is a specialized diagnostic assay used to detect the presence of specific autoantibodies in the blood. These autoantibodies target the myelin-associated glycoprotein (MAG), a crucial component of the myelin sheath that insulates nerve fibers in the central and peripheral nervous systems. The test is particularly relevant for diagnosing and monitoring certain autoimmune neuropathies, such as chronic inflammatory demyelinating polyneuropathy (CIDP) and other related conditions, where the immune system mistakenly attacks the body's own nerves.
Conducted at DNA Labs UAE, a leading laboratory with state-of-the-art facilities, the test ensures high accuracy and reliability. The cost of the MAG-SGPG IgM Test is set at 1490 AED, reflecting the sophisticated nature of the assay and the specialized expertise required to interpret the results. By identifying the presence of these autoantibodies, healthcare providers can better understand the underlying cause of neuropathic symptoms, allowing for more targeted and effective treatment strategies.
The "Cultured AFB Antitubercular DST Rapid 5 Drugs Panel Test" is a specialized diagnostic procedure designed to detect resistance against five key antitubercular drugs. This test is particularly valuable for patients diagnosed with tuberculosis (TB), as it aids in tailoring the most effective treatment regimen based on the sensitivity of the Mycobacterium tuberculosis strain to these medications. The panel typically includes drugs such as Isoniazid, Rifampicin, Ethambutol, Pyrazinamide, and Streptomycin, which are cornerstone treatments for TB.
Performed at DNA Labs UAE, a reputable facility known for its advanced diagnostic technologies and accuracy, the test involves culturing the bacteria from a patient's sputum or other clinical samples. Once the bacteria are grown, they are exposed to the drugs included in the panel to assess their susceptibility or resistance. This process is crucial for identifying multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), conditions that are more complex and challenging to treat.
The cost of the "Cultured AFB Antitubercular DST Rapid 5 Drugs Panel Test" at DNA Labs UAE is 1490 AED. While the price may seem high, the value of this test lies in its ability to significantly impact the treatment outcome by enabling healthcare providers to make informed decisions about the most effective and efficient therapy options for their patients.
The "Fish - Aneuploidy Detection Products of Conception (POC) Using Chromosomes 13, 18, 21, X, and Y Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify chromosomal abnormalities in fetal tissue following a miscarriage or pregnancy loss. This test specifically focuses on detecting aneuploidies, which are abnormalities in the number of chromosomes, in the most commonly affected chromosomes: 13, 18, 21, X, and Y. These particular chromosomes are chosen because their anomalies are associated with well-known genetic disorders, such as Down syndrome (Trisomy 21), Patau syndrome (Trisomy 13), and Edwards syndrome (Trisomy 18), along with sex chromosome abnormalities. The test is performed using Fluorescence In Situ Hybridization (FISH), a technique that allows for the visualization of specific chromosome abnormalities in the DNA of the fetal tissues. This method provides rapid and accurate results, aiding in the understanding of the genetic reasons behind the pregnancy loss. The cost of the test at DNA Labs UAE is 1470 AED, offering a valuable resource for parents seeking answers and genetic counseling for future pregnancies.
The "Fish - SRY Gene Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect the presence of the SRY gene, which is pivotal in determining male sex development. This test is particularly significant for assessing cases of ambiguous genitalia or disorders of sex development (DSD) by identifying the sex-determining region Y (SRY) gene located on the Y chromosome. It employs Fluorescence In Situ Hybridization (FISH) technology, a powerful technique that allows for the visualization of specific DNA sequences on chromosomes. The test is priced at 1470 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and reliability of results. This test is instrumental for clinicians in making informed decisions regarding the diagnosis, management, and counseling of individuals with sex development disorders.
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare, life-threatening disease characterized by the destruction of red blood cells, leading to hemoglobinuria, especially noticeable in the urine at night or in the early morning. This condition arises due to the absence of certain proteins on the surface of blood cells, making them susceptible to attack by the immune system.
To confirm a diagnosis of PNH, a specific test is conducted, known as flow cytometry, which is aimed at detecting the absence of these protective proteins on the surface of red blood cells, white blood cells, and platelets. This highly sensitive test is considered the gold standard for PNH diagnosis.
At DNA Labs UAE, this confirmatory test for PNH is available, ensuring accurate diagnosis with state-of-the-art technology. The test is priced at 1470 AED. It requires a blood sample, and the procedure is straightforward, involving minimal discomfort to the patient. The results from this test are crucial for the timely and appropriate management of PNH, allowing healthcare providers to tailor treatment plans that can significantly improve the quality of life for affected individuals.
Rett Syndrome Detection Test at DNA Labs UAE
Rett Syndrome is a rare, genetic neurological disorder that primarily affects girls and leads to severe impairments, affecting nearly every aspect of the child's life: their ability to speak, walk, eat, and even breathe easily. The key to managing Rett Syndrome effectively is early detection and intervention.
DNA Labs UAE offers a comprehensive Rett Syndrome Detection Test, designed to identify mutations in the MECP2 gene, which are responsible for most cases of the condition. This cutting-edge test is crucial for families seeking answers to developmental delays or other symptoms associated with Rett Syndrome. By providing a definitive diagnosis, the test enables healthcare providers to tailor interventions and support to meet the specific needs of the child, improving their quality of life.
The test cost is set at 1470 AED, reflecting the advanced genetic analysis involved and the expertise required to interpret the results accurately. Conducted in a state-of-the-art facility, DNA Labs UAE ensures that the process is as smooth and efficient as possible, with results that are both reliable and comprehensible. This test is a vital resource for families and physicians alike, offering hope and direction in the face of a challenging diagnosis.
